European Archives - Page 423 of 1334 - European Medical Journal

Key Predictors of Testosterone Recovery After Prostate Cancer Treatment

A study has provided new insights into testosterone recovery following androgen deprivation therapy in men undergoing radiotherapy for prostate cancer.

Impact of Airway Microbiome on Asthma Inflammation

New research reveals the significance of the airway microbiome in severe asthma, especially in ‘type-2 low’ neutrophilic asthma.

Genetic Mutations Linked to Early Menopause

Four genes with significant effects on the timing of menopause have been uncovered by a recent study offering insights into reproductive aging and cancer risks

The Effect of Exposure to Radiofrequency Fields on Cancer Risk

A review found no strong evidence linking radiofrequency electromagnetic fields from mobile phones and other sources to an increased risk of cancer, including brain tumours.

Prolonged Anticoagulation After COVID-19 Reduces Risk of Blood Clots: ERS 2024

Findings from ERS 2024 show that continuing anticoagulation after the acute phase of COVID-19 significantly reduces the risk of venous thromboembolism in recovering patients.

Increased Cancer Risk in Patients with Graves' Disease

A new South Korean study reveals that patients with Graves’ disease, an autoimmune thyroid disorder, may have an increased risk of developing cancers

Testosterone Exposure Doesn’t Affect Oocyte Cryopreservation in Gender-Diverse Individuals

Prior testosterone exposure does not negatively affect oocyte cryopreservation outcomes in transgender and gender-diverse adolescents and young adults.

New Approach Could Cut Gestational Diabetes Tests by 50%

Gestational diabetes screening in low-income countries faces challenges due to the accessibility of oral glucose tolerance tests. A study suggests early-pregnancy HbA1c testing, could reduce OGTT reliance

EMJ Cardiology 12 [Supplement 2] 2024

The emerging class of agents targeting factor XI/XIa offers the paradigm-shifting possibility of ‘haemostasis-sparing anticoagulation’…

Factor XI/XIa Inhibition: ESC Update

The emerging class of agents targeting factor XI/XIa offers the paradigm-shifting possibility of ‘haemostasis-sparing anticoagulation’…